Macular Thickness and Visual Acuity in Diabetic Hypertensive Patients
NCT ID: NCT05209971
Last Updated: 2022-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2022-01-31
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Diabetes Mellitus on Retinal Microvasculature in Patients Without Clinical Retinopathy Using Optical Coherence Tomography Angiography
NCT06457295
Research of the Correlation Between Metabolic Syndrome, Retinal Thickness and Visual Acuity
NCT01219478
Optical Coherence Tomography Angiography Criteria Of The Choroidal Neovascular Membrane In Wet Age Related Macular Degeneration And In Pathological Myopia (Comparative Study).
NCT05562336
Retinal Thickness Analysis Using Optical Coherence Tomography
NCT00797134
Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography
NCT05644548
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
macular thickness and visual acuity
optical coherence tomography
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Ocular disease ( such as high myopia , glaucoma ) .
* Patients with opacities in the media ( corneal opacities , dense cataract , vitreous hemorrhage ) .
* Systemic medication (Tamoxifen , Chloroquine , Canthaxanthine ) to avoid its effect on macular thickness .
* Central visual field defect that prevents fixation on OCT .
* Intraocular inflammation such as anterior or posterior uveitis .
* Refractive error greater than 6 diopter .
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raghda Abdelraheem Abdellah
principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raghda Abdelraheem, doctor
Role: PRINCIPAL_INVESTIGATOR
faculty of medicine
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med-22-01-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.